{"id":"W1965435352","doi":"10.3747/co.21.1736","title":"Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Current Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Leukemia and Lymphoma Society; American Society of Hematology","keywords":"Medicine; Discontinuation; Interquartile range; Myeloid leukemia; Nilotinib; Disease; Internal medicine; Tyrosine-kinase inhibitor; Family medicine; Imatinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002788414,0.0002755159,0.0005991477,0.0002311165,0.00007302094,0.00001152792,0.0001153649,0.0002029609,0.00009983563],"category_scores_gemma":[0.0003275739,0.0002379947,0.0001280974,0.0002184054,0.0001222034,0.00007697563,0.00009393347,0.000366086,0.00005839052],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0112082,"about_ca_system_score_gemma":0.002062754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007673982,"about_ca_topic_score_gemma":0.0002776619,"domain_scores_codex":[0.998,0.0001194137,0.0005540551,0.0005297117,0.0002157432,0.0005810967],"domain_scores_gemma":[0.9988497,0.0002958037,0.0002059244,0.0003500167,0.0001058914,0.0001925925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003276125,0.0005583225,0.02102127,0.000495124,0.00004791457,0.0000161899,0.0006735568,0.0001270818,0.004958976,0.0003423548,0.004555324,0.9668763],"study_design_scores_gemma":[0.02276925,0.008760585,0.04226471,0.001379709,0.0002409079,0.00006162631,0.0002498925,0.00915628,0.01102485,0.0006677426,0.9028563,0.0005681629],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894422,0.004738964,0.000313857,0.0003770173,0.001814673,0.00144855,0.00001503446,0.00008356348,0.001766195],"genre_scores_gemma":[0.9973843,0.0003450913,0.000574969,0.0001237219,0.0007744466,0.0005068248,0.0001669271,0.00003295998,0.00009077616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9663081,"threshold_uncertainty_score":0.9925876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06222247984834014,"score_gpt":0.3561808516265632,"score_spread":0.2939583717782231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}